139 related articles for article (PubMed ID: 322853)
41. A reappraisal of the Reed-Sternberg cell: a commentary.
Kadin ME
Blood Cells; 1980; 6(3):525-32. PubMed ID: 6994843
[No Abstract] [Full Text] [Related]
42. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
Walton RM; Hendrick MJ
Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
[TBL] [Abstract][Full Text] [Related]
43. Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease.
Orazi A; Jiang B; Lee CH; English GW; Cattoretti G; John K; Neiman RS
Am J Clin Pathol; 1995 Oct; 104(4):413-8. PubMed ID: 7572791
[TBL] [Abstract][Full Text] [Related]
44. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
[No Abstract] [Full Text] [Related]
45. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
Siebert JD; McClure SP; Banks PM; Gulley ML
Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
[TBL] [Abstract][Full Text] [Related]
46. Expression of the proliferating cell nuclear antigen in the different types of Hodgkin's disease.
Hell K; Lorenzen J; Hansmann ML; Fellbaum C; Busch R; Fischer R
Am J Clin Pathol; 1993 May; 99(5):598-603. PubMed ID: 7684186
[TBL] [Abstract][Full Text] [Related]
47. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
[TBL] [Abstract][Full Text] [Related]
48. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
49. B- and T-cell markers on canine lymphosarcoma cells.
Onions D
J Natl Cancer Inst; 1977 Sep; 59(3):1001-6. PubMed ID: 302340
[No Abstract] [Full Text] [Related]
50. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
[TBL] [Abstract][Full Text] [Related]
51. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
52. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
Wu D; Thomas A; Fromm JR
Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
[TBL] [Abstract][Full Text] [Related]
53. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
54. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
[TBL] [Abstract][Full Text] [Related]
55. Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease.
Linden MD; Fishleder AJ; Katzin WE; Tubbs RR
Hum Pathol; 1988 May; 19(5):591-4. PubMed ID: 3131233
[TBL] [Abstract][Full Text] [Related]
56. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
Cohnen G
Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
[TBL] [Abstract][Full Text] [Related]
57. C3 receptor. A marker of a thymus-dependent B-cell subpopulation.
Arnaiz-Villena A; Playfair JH; Roitt IM
Clin Exp Immunol; 1975 May; 20(2):375-8. PubMed ID: 1082391
[TBL] [Abstract][Full Text] [Related]
58. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
Imam A; Stathopoulos E; Taylor CR
Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
[TBL] [Abstract][Full Text] [Related]
59. Surface markers on canine lymphocytes.
Zander AR; Boopalam N; Epstein RB
Transplant Proc; 1975 Sep; 7(3):369-73. PubMed ID: 1099741
[No Abstract] [Full Text] [Related]
60. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease.
Facchetti F; De Wolf-Peeters C; van den Oord JJ; Desmet VJ
J Pathol; 1989 May; 158(1):57-65. PubMed ID: 2787853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
